On the basis of these results, we used CSF and serum from patients with intracranial hypertension for control and showed that CCL4 was significantly higher in both the inflammatory and tumor groups than in the control group (Supplementary Figures 1, 2). Here, CCL4 is linked to intracranial hypertension.